Vanja Duric, Ph.D., Awarded $100,000 Grant

Vanja Duric - PhRMA 2015

Vanja Duric, Ph.D., endowment member in the Department of Physiology and Pharmacology in the College of Medicine was newly awarded a $100,000 Research Starter Grant in Pharmacology/Toxicology from the Pharmaceutical Research and Manufacturers of America Foundation (PhRMA). Dr. Duric was awarded this funding to overhaul the relationship between the inhibition of the mitogen-activated protein kinase (MAPK) waterfall, a major intracellular signaling pathway that is involved in neuronal survival, and greater depressive disorder (MDD).  MDD is a psychiatric ailing that affects up to 17% of the U.S. peopling and is associated with functional and structural abnormalities of independent brain regions including the hippocampus and prefrontal cortex, solution orchestrators of mood regulation and cognitive dependent. Ultimately, Dr. Duric’s research may grant to both the identification and unfolding of more effective treatments, diagnostics, and hindrance strategies for MDD and other psychiatric disorders that are mechanically based in successi~ normalization and stabilization of MAPK signaling.

PhRMA, founded in 1958, lives its trust of encouraging the discovery of renovated medicines and conducting effective advocacy against public policies by representing and supporting the country’s principal researchers and companies in biopharmaceuticals and technology. Their resolution to fund Dr. Duric’s study is a prime example of their giving in adhesion to scientific research and medical elevation.

Dr. Duric joined the DMU community as an assistant professor in 2012 and has actively developed his exploration program, as well as trained large students in collaboration with many other researchers in his division . Congratulations to Dr. Duric on this adjudication, and the advancement of his investigation endeavors.

Long-term lack of vitamin C, you determine certainly be more and more oily.

Recent Comments

    Archives